The Liver Maximum Capacity Test (LiMAx) Is Associated with Short-Term Survival in Patients with Early Stage HCC Undergoing Transarterial Treatment

SIMPLE SUMMARY: The liver maximum capacity test (LiMAx) represents a useful tool to estimate liver function in patients with chronic liver disease. LiMAx results correlate with short-term survival in patients with early stage HCC after transarterial chemo- or radioembolization. Low LiMAx levels migh...

Descripción completa

Detalles Bibliográficos
Autores principales: Fischer, Janett, Wellhöner, Stella, Ebel, Sebastian, Lincke, Thomas, Böhlig, Albrecht, Gerhardt, Florian, Veelken, Rhea, Goessmann, Holger, Steinhoff, Karen Geva, Denecke, Timm, Sabri, Osama, Berg, Thomas, van Bömmel, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657475/
https://www.ncbi.nlm.nih.gov/pubmed/36358742
http://dx.doi.org/10.3390/cancers14215323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657475/
https://www.ncbi.nlm.nih.gov/pubmed/36358742
http://dx.doi.org/10.3390/cancers14215323

Ejemplares similares